457 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 10 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP1AMicrotubule-associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAP4Microtubule-associated protein 4FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK11Mitogen-activated protein kinase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPTMicrotubule-associated protein tauCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP11Matrix metallopeptidase 11 (stromelysin 3)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP14Matrix metallopeptidase 14 (membrane-inserted)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
MMP16Matrix metallopeptidase 16 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP2Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
MMP21Matrix metallopeptidase 21Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP23BMatrix metallopeptidase 23BEnzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
MMP24Matrix metallopeptidase 24 (membrane-inserted)Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP27Matrix metallopeptidase 27Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP3Matrix metallopeptidase 3 (stromelysin 1, progelatinase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
MMP7Matrix metallopeptidase 7 (matrilysin, uterine)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MTORMechanistic target of rapamycin (serine/threonine kinase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MTR5-methyltetrahydrofolate-homocysteine methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
MTTPMicrosomal triglyceride transfer proteinDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
MUTMethylmalonyl CoA mutaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Expressed in all
NFKB1Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Transcription factors
Expressed in all
NNMTNicotinamide N-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
NOS2Nitric oxide synthase 2, inducibleCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
NOS3Nitric oxide synthase 3 (endothelial cell)Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
NOXO1NADPH oxidase organizer 1FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
NPC1L1NPC1-like 1FDA approved drug targets
Predicted membrane proteins
Group enriched
NPR1Natriuretic peptide receptor 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
NPR2Natriuretic peptide receptor 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Mixed
NR3C1Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
NR3C2Nuclear receptor subfamily 3, group C, member 2Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
NTRK1Neurotrophic tyrosine kinase, receptor, type 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
OPRD1Opioid receptor, delta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
OPRK1Opioid receptor, kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced

« prev | Page of 10 | next »